1. Reduced Biofilm Accumulation on Implants Treated With Implantoplasty—An In Situ Trial With a Within‐Subject Comparison
- Author
-
Kristina Bertl, Mohammad Al‐Said, Ahmed Mourad, Magdalena Mayol, Zita Lopes da Silva, Evaggelia Papia, and Andreas Stavropoulos
- Subjects
biofilm ,crystal violet assay ,implant surface ,implantoplasty ,peri‐implantitis ,Dentistry ,RK1-715 - Abstract
ABSTRACT Objectives This study aimed to evaluate potential differences in biofilm accumulation on three different implant surfaces: turned surface (TS), modified surface (MS), and modified surface treated with implantoplasty (IPS), using a within‐subject comparison. Material and Methods Ten volunteers wore individualized splints containing three titanium implants with different surfaces (TS, MS, and IPS) on each buccal side of the splint. The implant position (anterior, central, and posterior) was randomly assigned among the three implants on each side. Volunteers were instructed to wear the splint for 72 h and to remove it only for eating, drinking, and performing standard oral hygiene; the splint itself was not cleaned. After 72 h, the implants were carefully removed from the splint, and the accumulated biofilm was assessed using a crystal violet assay by measuring intensity/absorbance at 570 nm. Results All volunteers reported no deviations from the instructions. The lowest mean amount of biofilm (0.405 ± 0.07) was detected on implants of the IPS group, followed by implants of the MS (0.463 ± 0.06) and TS group (0.467 ± 0.07). A multilevel mixed‐effects linear regression analysis confirmed that implants of the IPS group accumulated a significantly lower amount of biofilm than the other surfaces (p
- Published
- 2024
- Full Text
- View/download PDF